Mycotopia Therapy News Today

Press release content from Globe Newswire. The AP news staff was not involved in its creation. 4 Top Stocks for Huge Gains from the Psychedelic Renaissance OTC Stock ReviewJanuary 25, 2021 GMT ATLANTA, Jan. 25, 2021 (GLOBE NEWSWIRE) -- OTC Stock Review was early to the party with an article on Seeking Alpha March 6, 2020 titled ” Psychedelic Medicine Stocks Capture the Attention of Investors.” Even though several of today’s market leaders were not public last March, since then several of ...

News Category Global Banking & Finance Reviews Ehave, Inc. Closes 20/20 Global Transaction, Mycotopia Therapy Now Operating as a Publicly Traded Company with Intent to Focus on Psychedelic Sector Ehave, Inc. Closes 20/20 Global Transaction, Mycotopia Therapy Now Operating as a Publicly Traded Company with Intent to Focus on Psychedelic Sector MIAMI, Jan. 20, 2021 — Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a leader in digital therapeutics, announced today the Company has closed the t...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

[December 28, 2020] Ehave, Inc. Announces Repositioning of Mycotopia Therapies to Maximize Shareholder Value MIAMI, Dec. 28, 2020 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a leader in digital therapeutics and developer of KetaDASH, a home delivery platform for patients who have been prescribed Ketamine infusions, announced today the Companys Board of directors has elected to sell 100% of its Mycotopia Therapies subsidiary to 20/20 Global Inc. (OTC Pink: TWGL) ...